Notch2 blockade enhances hematopoietic stem cell mobilization and homing

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Autologous hematopoietic cell transplantation (HCT) relies on effective mobilization of hematopoietic progenitor cells (HPCs).
• Current mobilization strategies may be insufficient for some patients, leading to complications.
• Notch signaling plays a role in maintaining hematopoietic stem cell quiescence.

Purpose of the Study:

• To investigate the role of Notch signaling in hematopoietic progenitor cell mobilization.
• To determine if blocking Notch receptors can enhance HPC mobilization for HCT.

Main Methods:

• Utilized Notch receptor blocking antibodies (Notch1 and Notch2) in preclinical models.
• Assessed hematopoietic stem and progenitor cell (HSPC) mobilization, migration, and engraftment.
• Analyzed CXCR4 expression and cell cycling in response to Notch blockade.

Main Results:

• Notch2 blockade, but not Notch1, sensitized HSPCs to mobilization stimuli, increasing their egress from marrow.
• Notch2 blockade led to transient myeloid progenitor expansion without affecting HSC homeostasis.
• Decreased CXCR4 expression and increased cell cycling were observed in Notch2-blocked HSPCs, with RBPJ regulating CXCR4 transcription.
• Mobilized HSPCs exhibited enhanced homing and a competitive repopulating advantage.

Conclusions:

• Transient Notch2 blockade enhances HPC mobilization and engraftment potential.
• Combining Notch2 blockade with current HCT regimens may improve patient outcomes.
• Targeting Notch2 offers a promising strategy for optimizing HCT procedures.